HIGHLIGHTS   |  April 9, 2020   Dr. Scott Lipkin on Diversity in Clinical Trials at Miami Cancer Institute The Miami Cancer Institute is one of the leading organizations in diversity amongst its clinical trials, and chief research officer Scott Lipkin, DPM, CIP, spoke on the present and future of diversity within the organization. Read more ADVERTISEMENT   Methods for Assessing Familial Breast Cancer Risk Depend on Study Purpose This study assessed whether the accumulative, static, or dynamic method was best suited for determining the familial risk of breast cancer. Read more   In Case You Missed It

Decrease in Bone Mineral Density After Pelvic Radiotherapy in Gynecologic Cancers These findings indicate that bone mineral density screening and pharmacologic intervention should be strongly considered for these high-risk women. Read more